Open Access
Review
Nutrition in oncologic patients during antiblastic treatment
Massimiliano Berretta1,*,Mariagrazia Michieli1,Raffaele Di Francia2,Alessandro Cappellani3,Maurizio Rupolo1,Fabio Galvano4,Rossella Fisichella3,Salvatore Berretta3,Umberto Tirelli1
1
Department of Medical Oncology, National Cancer Institute Aviano (Pn), Italy
2
Laboratory of Molecular Hematology, National Cancer Institute, G. Pascale, Naples, Italy
3
Department of Surgery, University of Catania, Catania, Italy
4
Department of Biological Chemistry, Medical Chemistry, Molecular Biology, University of Catania, Catania, Italy
DOI: 10.2741/4091 Volume 18 Issue 1, pp.120-132
Published: 01 January 2013
(This article belongs to the Special Issue Dietary approaches to prevent chronic-degenerative diseases)
*Corresponding Author(s):  
Massimiliano Berretta
E-mail:  
mberretta@cro.it
Abstract

Cancer may induce weight loss and cachexia, and cancer treatment may contribute to nutritional impairment. Here, we review the literature on the mechanisms of cancer cachexia and the pharmacological interventions both in use in clinical practice and currently under development. Based on this analysis, several nutritional proposals for cancer patients are suggested and the importance of good nutritional status in candidates for hematopoietic stem cell transplantation is highlighted.

Key words

Antiblastic chemotherapy, Cancer, Foods, Hematopoietic stem cell transplantation, Review

Share and Cite
Massimiliano Berretta, Mariagrazia Michieli, Raffaele Di Francia, Alessandro Cappellani, Maurizio Rupolo, Fabio Galvano, Rossella Fisichella, Salvatore Berretta, Umberto Tirelli. Nutrition in oncologic patients during antiblastic treatment. Frontiers in Bioscience-Landmark. 2013. 18(1); 120-132.